|
|
|
41
|
A691L
|
OXCARBAZEPINE 300MG TAB (CAM)
|
OXCARBAZEPINE
|
OXCARBAZEPINE
|
50'S
|
A
|
23.46
|
0.4692
|
TAB
|
120
|
BOTT
|
CAM
|
MORNINGSIDE PHARMACEUTICALS
|
ATB
|
ANSA TRADING BARBADOS LTD
|
B
|
281292
|
ANTICONVULSANTS MISCELLANEOUS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
ANTICONVULSANTS MISCELLANEOUS
|
|
|
|
|
41
|
A691N
|
APO-OXCARBAZEPINE 300MG TAB (APO) O
|
OXCARBAZEPINE
|
APO-OXCARBAZEPINE
|
100'S
|
A
|
60.62
|
0.6062
|
TAB
|
120
|
BOTT
|
APO
|
APOTEX INC.
|
ATB
|
ANSA TRADING BARBADOS LTD
|
B
|
281292
|
ANTICONVULSANTS MISCELLANEOUS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
ANTICONVULSANTS MISCELLANEOUS
|
|
|
|
|
40
|
A692E
|
APO-OXCARBAZEPINE 600MG TAB (APO/COL)
|
OXCARBAZEPINE
|
APO-OXCARBAZEPINE
|
100'S
|
A
|
78.83
|
0.79
|
TABLET
|
120
|
TAB
|
APO
|
APOTEX INC.
|
COL
|
COLLINS LTD
|
B
|
281292
|
ANTICONVULSANTS MISCELLANEOUS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
CENTRAL NERVOUS SYSTEM DRUGS
|
|
|
|
|
41
|
A692F
|
OXCARBAZEPINE 600MG TAB (CAM)
|
OXCARBAZEPINE
|
OXCARBAZEPINE
|
50'S
|
A
|
37.68
|
0.7535
|
TAB
|
120
|
BOTT
|
CAM
|
MORNINGSIDE PHARMACEUTICALS
|
ATB
|
ANSA TRADING BARBADOS LTD
|
B
|
281292
|
ANTICONVULSANTS MISCELLANEOUS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
ANTICONVULSANTS MISCELLANEOUS
|
|
|
|
|
41
|
A692H
|
APO-OXCARBAZEPINE 600MG TAB (APO) O
|
OXCARBAZEPINE
|
APO-OXCARBAZEPINE
|
100'S
|
A
|
80.41
|
0.8041
|
TAB
|
120
|
BOTT
|
APO
|
APOTEX INC.
|
ATB
|
ANSA TRADING BARBADOS LTD
|
B
|
281292
|
ANTICONVULSANTS MISCELLANEOUS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
ANTICONVULSANTS MISCELLANEOUS
|
|
|
|
|
40
|
A6931
|
TRILEPTAL 60MG/ML SUSP (NVS/COL) OXCARBAZEPIN
|
OXCARBAZEPINE
|
TRILEPTAL
|
100ML
|
A
|
27.35
|
0.27
|
SUSPENSION
|
600
|
ML
|
NVS
|
NOVARTIS CARIBE SA
|
COL
|
COLLINS LTD
|
B
|
281292
|
ANTICONVULSANTS MISCELLANEOUS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
CENTRAL NERVOUS SYSTEM DRUGS
|
|
|
|
|
41
|
A6931
|
TRILEPTAL 60MG/ML SUSP (NVS) OXCARBAZEPI
|
OXCARBAZEPINE
|
TRILEPTAL
|
100ML
|
A
|
27.35
|
0.2735
|
ML
|
600
|
BOTT
|
NVS
|
NOVARTIS CARIBE SA
|
COL
|
COLLINS LTD
|
B
|
281292
|
ANTICONVULSANTS MISCELLANEOUS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
ANTICONVULSANTS MISCELLANEOUS
|
|
|
|
|
40
|
A7017
|
PILOCARPINE | TIMOLOL 2% | 0.5% EYE DR (FSB/ATB)
|
PILOCARPINE|TIMOLOL
|
PILOCARPINE|TIMOLOL
|
5ML
|
A
|
5.76
|
5.76
|
EYE DROP
|
1
|
BOTT
|
FSB
|
FLAGSHIP BIOTECH
|
ATB
|
ANSA TRADING BARBADOS LTD
|
B
|
524092
|
ANTIGLAUCOMA AGENTS MISCELLANEOUS
|
2022-04-01
|
2024-03-31
|
Price Change
|
Ophthalmic
|
6
|
EYE, EAR, NOSE AND THROAT PREPARATIONS
|
2021-12-08
|
|
|
|
40
|
A7026
|
PILOCARPINE | TIMOLOL 4% | 0.5% EYE DR (FSB/ATB)
|
PILOCARPINE|TIMOLOL
|
PILOCARPINE|TIMOLOL
|
5ML
|
A
|
7.04
|
7.04
|
EYE DROP
|
1
|
BOTT
|
FSB
|
FLAGSHIP BIOTECH
|
ATB
|
ANSA TRADING BARBADOS LTD
|
B
|
524092
|
ANTIGLAUCOMA AGENTS MISCELLANEOUS
|
2022-04-01
|
2024-03-31
|
Price Change
|
Ophthalmic
|
6
|
EYE, EAR, NOSE AND THROAT PREPARATIONS
|
2021-12-08
|
|
|
|
40
|
A7111
|
RISPERDAL 2MG TAB (JAC/STO) RISPERIDONE
|
RISPERIDONE
|
RISPERDAL
|
20'S
|
BP
|
19.41
|
0.97
|
TABLET
|
60
|
TAB
|
JAC
|
JANSSEN-CILAG
|
STO
|
BRYDEN STOKES LTD
|
|
28160804
|
ATYPICAL ANTIPSYCHOTICS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
CENTRAL NERVOUS SYSTEM DRUGS
|
|
|
|
|
41
|
A7111
|
RISPERDAL 2MG TAB (JAC) RISPERIDONE (C)
|
RISPERIDONE
|
RISPERDAL
|
20'S
|
C
|
19.41
|
0.9704
|
TAB
|
60
|
BOX
|
JAC
|
JANSSEN-CILAG
|
STO
|
BRYDEN STOKES LTD
|
|
28160804
|
ATYPICAL ANTIPSYCHOTICS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
ATYPICAL ANTIPSYCHOTICS
|
|
|
|
|
40
|
A7117
|
APO-RISPERIDONE 2MG TAB (APO/COL)
|
RISPERIDONE
|
APO-RISPERIDONE
|
100'S
|
A
|
10.87
|
0.11
|
TABLET
|
60
|
TAB
|
APO
|
APOTEX INC.
|
COL
|
COLLINS LTD
|
|
28160804
|
ATYPICAL ANTIPSYCHOTICS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
CENTRAL NERVOUS SYSTEM DRUGS
|
|
|
|
|
40
|
A711AB
|
RISPERIDONE 2MG TAB (INP/AHI)
|
RISPERIDONE
|
RISPERIDONE
|
50'S
|
A
|
1.20
|
0.02
|
TABLET
|
60
|
TAB
|
INP
|
INTAS PHARMACEUTICALS LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
28160804
|
ATYPICAL ANTIPSYCHOTICS
|
2022-04-01
|
2022-09-30
|
|
Oral
|
6
|
CENTRAL NERVOUS SYSTEM DRUGS
|
2022-03-29
|
|
|
|
41
|
A711AB
|
RISDONE 2MG TAB (INP) RISPERIDONE
|
RISPERIDONE
|
RISDONE
|
50'S
|
A
|
4.49
|
0.0897
|
TAB
|
60
|
BOX
|
INP
|
INTAS PHARMACEUTICALS LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
28160804
|
ATYPICAL ANTIPSYCHOTICS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
ATYPICAL ANTIPSYCHOTICS
|
|
|
|
|
40
|
A711AK
|
RISDONE 2MG TAB (INP/AHI) RISPERIDONE
|
RISPERIDONE
|
RISDONE
|
60'S
|
A
|
7.83
|
0.13
|
TABLET
|
60
|
TAB
|
INP
|
INTAS PHARMACEUTICALS LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
28160804
|
ATYPICAL ANTIPSYCHOTICS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
CENTRAL NERVOUS SYSTEM DRUGS
|
|
|
|
|
41
|
A711AL
|
APO-RISPERIDONE 2MG TAB (APO)
|
RISPERIDONE
|
APO-RISPERIDONE
|
100'S
|
A
|
11.09
|
0.1109
|
TAB
|
60
|
BOTT
|
APO
|
APOTEX INC.
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
28160804
|
ATYPICAL ANTIPSYCHOTICS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
ATYPICAL ANTIPSYCHOTICS
|
|
|
|
|
40
|
A7121
|
RISPERDAL 1MG TAB (JAC/STO) RISPERIDONE
|
RISPERIDONE
|
RISPERDAL
|
20'S
|
BP
|
19.41
|
0.97
|
TABLET
|
60
|
TAB
|
JAC
|
JANSSEN-CILAG
|
STO
|
BRYDEN STOKES LTD
|
|
28160804
|
ATYPICAL ANTIPSYCHOTICS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
CENTRAL NERVOUS SYSTEM DRUGS
|
|
|
|
|
41
|
A7121
|
RISPERDAL 1MG TAB (JAC) RISPERIDONE (C)
|
RISPERIDONE
|
RISPERDAL
|
20'S
|
C
|
19.41
|
0.9704
|
TAB
|
84
|
BOX
|
JAC
|
JANSSEN-CILAG
|
STO
|
BRYDEN STOKES LTD
|
|
28160804
|
ATYPICAL ANTIPSYCHOTICS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
ATYPICAL ANTIPSYCHOTICS
|
|
|
|
|
40
|
A7126
|
APO-RISPERIDONE 1MG TAB (APO/COL)
|
RISPERIDONE
|
APO-RISPERIDONE
|
100'S
|
A
|
10.87
|
0.11
|
TABLET
|
60
|
TAB
|
APO
|
APOTEX INC.
|
COL
|
COLLINS LTD
|
|
28160804
|
ATYPICAL ANTIPSYCHOTICS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
CENTRAL NERVOUS SYSTEM DRUGS
|
|
|
|
|
40
|
A712AD
|
RISPERIDONE 1MG TAB (INP/AHI)
|
RISPERIDONE
|
RISPERIDONE
|
50'S
|
A
|
1.09
|
0.02
|
TABLET
|
60
|
TAB
|
INP
|
INTAS PHARMACEUTICALS LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
28160804
|
ATYPICAL ANTIPSYCHOTICS
|
2022-04-01
|
2022-09-30
|
|
Oral
|
6
|
CENTRAL NERVOUS SYSTEM DRUGS
|
2022-03-29
|